Welcome to our dedicated page for Wearable Devices Ltd. SEC filings (Ticker: WLDS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wearable Devices Ltd. filings document its foreign private issuer reporting for AI-powered touchless sensing wearables, Mudra neural input products and software platforms for XR, mobile and AI applications. Form 6-K reports furnish product announcements, patent notices, financial results and updates on ai6 Labs, Mudra Experience Studio, Mudra Link and Mudra Band.
The filings also cover capital-structure and governance matters, including ordinary shares and tradable warrants, reverse share split disclosure, shareholder meeting results, compensation policy amendments, equity incentive plan share reserves, and incorporation by reference into Form S-8 and Form F-3 registration statements.
Wearable Devices Ltd. held a special shareholder meeting where a quorum was reached after an adjournment and all seven proposals were approved. A key outcome was adoption of an amended and restated compensation policy for executives and directors.
The updated policy increases the chief executive officer’s maximum base salary and raises annual bonus caps. It also revises the mix between fixed and variable pay by role, expands equity-based compensation limits for office holders, and increases the maximum annual equity grants for directors. The detailed policy, dated September 2025, is attached as an exhibit and will govern salaries, bonuses, equity awards, change-of-control treatment and clawback mechanisms for the company’s office holders.
Wearable Devices Ltd. Schedule 13G shows Armistice Capital, LLC and Steven Boyd jointly report beneficial ownership of 619,818 ordinary shares, representing 9.99% of the class as of 12/31/2025. The shares are held directly by Armistice Capital Master Fund Ltd., for which Armistice Capital acts as investment manager and exercises voting and dispositive power under an Investment Management Agreement; the Master Fund disclaims beneficial ownership due to its inability to vote or dispose of the securities under that agreement. The joint filing is signed by Steven Boyd and dated 02/17/2026.
Wearable Devices Ltd. filed a Form 6-K highlighting a strategic product initiative and leadership appointment. The company plans to launch the Mudra Experience Studio, a developer platform that turns its neural input technology into a universal gesture language for extended reality (XR), mobile, desktop, and AI-powered applications.
The platform will offer production-ready SDKs, standardized gesture taxonomy, and integration with AI-driven development tools, aiming to let developers build once and deploy across Apple, Meta, Android XR, and desktop ecosystems. Wearable Devices opened a priority waitlist to support a 2026 rollout and reports strong early developer interest.
The company also appointed Ron Kaldes as Head of Growth, AI & Innovation to help drive the ai6 Labs and Mudra Experience Studio strategy, leveraging his background in consumer technology and AI consulting. The filing incorporates parts of this press release into existing S-8 and F-3 registration statements.
Wearable Devices Ltd. has launched ai6 Labs, a neural AI ecosystem designed to bridge human intent with digital reality using non-invasive Electromyography and its Mudra technology. The platform links foundational research, product commercialization, and rapid AI experimentation into a closed-loop system intended to accelerate innovation in touchless, intent-driven human–machine interaction.
The company positions ai6 Labs as a three-pillar ecosystem that turns biological signals into digital commands in a faster and more scalable way. Management describes this as an inflection point for AI wearables, extended reality gesture control, and non-invasive brain–computer interfaces, supporting its broader neural input product strategy.
Wearable Devices Ltd. appointed Kobbi Nir as an independent director to its Board of Directors. He is classified as a Class II director and is expected to be submitted for re-appointment at the company’s 2027 Annual General Meeting.
Mr. Nir will serve on the Board’s audit committee and compensation committee, bringing experience as CFO and deputy CEO of Moodify Ltd. and prior senior finance and board roles. He replaces Yaacov Goldman, who stepped down from the Board effective January 31, 2026, with the company stating his resignation was not due to any disagreement over operations, policies, or practices.
Wearable Devices Ltd. filed a post-effective amendment to end two prior Form F-1 resale registrations tied to warrant financings completed in 2024 and 2025. The first registration covered up to 205,500 ordinary shares underlying November 2024 warrants, and the second covered up to 625,000 ordinary shares underlying January 2025 warrants, both for a single investor.
The company states that the selling shareholder has sold all ordinary shares underlying both the November and January warrants and that its contractual obligation to keep each registration statement effective has expired. As a result, Wearable Devices is terminating the related offerings and deregistering any ordinary shares that may remain unsold under those registration statements.
Wearable Devices Ltd. filed a post-effective amendment to close out two previously effective Form F-1 resale registration statements and deregister any remaining unsold ordinary shares. These earlier filings covered the resale of up to 205,500 ordinary shares underlying November 2024 warrants and up to 625,000 ordinary shares underlying January 2025 warrants issued to a single investor in prior financing transactions. The company’s contractual obligation to keep each registration statement effective has expired because the selling shareholder has sold all the warrant shares or can sell them under Rule 144. Wearable Devices has now terminated the related offerings and amended the registration statements to remove from registration any ordinary shares that may still be unsold and to terminate the effectiveness of both registration statements.